The traveler’s diarrhea market is primarily propelled by the increasing instances of viral, bacterial, and parasitic infections due to inadequate public hygiene, leading to food and water contamination.

1. Traveler’s Diarrhea
Market Research
Report 2023-2033

2. ABOUT IMARC
2
International Market Analysis Research and Consulting Group is a
leading adviser on management strategy and market research
worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific,
economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of
the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into
the dynamics of companies and markets with close cooperation at
all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient
organizations, and secure lasting results.

3. Report Description and Highlights
Traveler’s Diarrhea Market 2023-2033
The newly published report by IMARC Group, titled ”Traveler’s Diarrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity,
and Forecast 2023-2033″, presents a comprehensive analysis of the traveler’s diarrhea market size The report provides an overview of the
market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market
scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the seven major
markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.
What is traveler’s diarrhea market?
Traveler’s diarrhea refers to a digestive tract disorder that occurs from the consumption of contaminated food or water while traveling. It is
most commonly triggered by E. coli bacteria but can also originate from other pathogens like viruses and parasites. Symptoms often involve
abdominal cramps, nausea, vomiting, frequent watery bowel movements, bloating, loss of appetite, and an urgency to defecate. Severe cases
can manifest as dehydration, dry mouth, fatigue, weakness, bloody stools, headaches, dizziness, and electrolyte imbalances. The diagnosis of
traveler’s diarrhea relies on the patient’s symptoms and detailed travel history. A range of medical exams, stool cultures, and polymerase chain
reaction (PCR) tests are conducted to assess the individual’s health and exclude other potential diseases. 3

4. Report Description and Highlights
What are the key drivers and trends in the traveler’s diarrhea market?
The traveler’s diarrhea market is primarily propelled by the increasing instances of viral, bacterial, and parasitic infections due to
inadequate public hygiene, leading to food and water contamination. Rising cases of risk factors like young adult travelers, poor dietary
habits, and compromised immunity also contribute to market growth. The widespread use of antimotility agents such as loperamide and
diphenoxylate, which manage symptoms by controlling gastrointestinal muscle spasms and decreasing bowel movement frequency, acts as
another significant growth catalyst. The expanding application of lifestyle modifications like consuming bananas, rice, applesauce, and toast
(BRAT) diet, which assists in alleviating stomach distress and preventing dehydration, is further enhancing market growth. The rising
popularity of oral rehydration solutions, which optimize fluid absorption in the intestines and rapidly restore body electrolytes, is
anticipated to drive the traveler’s diarrhea market in future years.
Request a Sample Report: https://www.imarcgroup.com/travelers-diarrhea-market/requestsample
4

5. Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033
Countries Included:
• United States
• Germany
• France
5

6. Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Traveler’s Diarrhea market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Traveler’s Diarrhea market
• Reimbursement scenario in the market
• In-market and pipeline drugs
6

7. Report Description and Highlights
In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status
View Report TOC, Figures and Tables: https://www.imarcgroup.com/travelers-diarrhea-market
7

8. Key Questions Answered in the Report
1. How has the Traveler’s Diarrhea Market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
3. What was the country-wise size of the Traveler’s Diarrhea Market across the seven major markets in 2022 and what will it look like in
2033?
4. What is the growth rate of the Traveler’s Diarrhea Market across the seven major markets and what will be the expected growth over
the next ten years?
5. What are the key unmet needs in the market?
8

9. Table of
Contents

10. Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
10

11. Table of Contents
4 Traveler’s Diarrhea - Introduction
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2017-2022) and Forecast (2023-2033)
4.4 Market Overview (2017-2022) and Forecast (2023-2033)
4.5 Competitive Intelligence
5 Traveler’s Diarrhea - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/travelers-diarrhea-market/toc
11

12. Partial List Of Our Clients
12

13. OUR CLIENTS
13

14. Disclaimer
14
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis
Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or
in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including
photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information
and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting
makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts
no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and
Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.